A devastated family has spoken of their ‘heartbreak’ after learning their ‘funny, kind and loving’ 15 year-old son has an ...

Telix (ASX:TLX) has copped a sharp jab on Monday as the FDA says its drug TLX101-CDx, AKA Floretyrosine, can’t be accepted ...

Telix Pharmaceuticals said it received a "disappointing outcome" from the US Food and Drug Administration (FDA), after the ...

New targeted delivery technology offers hope for aggressive brain cancer treatment.

The U.S. FDA issued a complete response letter (CRL) to Telix Pharmaceuticals Ltd. for its NDA for glioma imaging agent, TLX-101-CDx (floretyrosine F18 or 18F-FET, Pixclara), citing the need for ...

Telix has been shocked by the US Food & Drug Administration's rejection of marketing approval for its brain cancer diagnostic ...

Researchers have developed an AI system that predicts brain tumor recurrence in children using sequential MRI scans. By ...

Personalized Tumor-Specific Amplified DNA Junctions in Peripheral Blood of Patients with High-Grade Gliomas - ...

Neurosurgery experts from UCSF Health will present new research and clinical findings at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in Boston, April 25-28.

Researchers have developed an AI model that analyzes sequences of brain scans to accurately predict tumor recurrence in children with gliomas.

The award-winning Powys-based soft drinks producer employee is hoping to raise money for Abbie’s Army, a brain cancer charity which funds medical research to give hope to families. Abbie Mifsud was ...

Researchers trained and validated a deep learning model that can detect subtle changes across post-treatment brain scans and forecast glioma recurrence with up to 89 percent accuracy.